Business Segments Vector Science and Therapeutics Corp.
Stocks
PAIN
CA92244M1041
Investment Holding Companies
|
Market Closed -
Toronto S.E.
03:59:55 07/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 1.750 CAD | -7.89% |
|
-6.42% | +3,400.00% |
| 08-24 | Vector Science Starts Manufacturing Pharma-Grade Peptides | MT |
| 08-24 | Vector Science & Therapeutics Increases Peptide Manufacturing Capacity At Lyogenesis Facility | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Geographical Revenue Distribution History
Breakdown by Business Segment (USD)
| Fiscal Period: August | 2024 | 2025 |
|---|---|---|
Drug Delivery Technologies | ||
EBT | - | -898K |
Net Income | - | -898K |
Total Assets | 600 | 3.01M |
Geographical breakdown of sales (USD)
| Fiscal Period: August | 2024 | 2025 |
|---|---|---|
Net Income | - | -898K |
EBT | - | -898K |
Total Assets | 600 | 3.01M |
- Stock Market
- Stocks
- PAIN Stock
- Financials Vector Science and Therapeutics Corp.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
